Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
Great news about the sale but there is a negative line at the end of the RNS. "All the key hardware, including the proton accelerating structures to accelerate protons to 230 MeV and patient positioning system, required for the certification of our first full-energy LIGHT system in Daresbury, UK, has been manufactured"
they were all manufactured in the middle of last year and we were waiting for them all to be delivered to Daresbury by the end of 2019. This hasn't happened because I am sure there would have been an RNS to tell us. The company hasn't replied to my email to them asking that exact question. WIll this delivery delay eat into the first patient treated? probably, does that matter? probably not as long as they get it to work so they can get regulatory approval to allow sales such as these.
Good announcement but they are nearly 2 months behind their schedule. They were meant to have all of the components of the light Machine by the end of 2020 ready for construction and validation in 2020. There has been no RNS to say they hit those deadlines and the remaining components are in STFC Daresbury. Every week that goes by without all of the components is time added on at the end.
That is bizarre why there hasn't been an RNS with that information! If it is true it is really important. They didn't put anything on social media about the Bioworld article. Very strange but good news if true. Well spotted Vanilla.
I agree Bimini. either the suppliers have missed the deadline to deliver or AVO has failed to inform us. I really hope it's the latter. It doesn't bode well for building 8 machines a year if the suppliers can's get the parts to them on time. Plus it's a month worth of validation time they have lost due to not having the components.
Neil has stated many times all his personal wealth is invested in his funds. Equity income is gated so he can’t sell any units he holds there and he’s not taking any dividend or wages from WIM so selling some of his wpct shares is not a sign he doesn’t believe in the trust.
Although it does imply we won’t know if the machine can produce 230mev until at least early 2020 due to the final 7 CCLs not being delivered until early Q4 2019. And then you have what ever work is involved with integrating them into the system.
When you look at the timeline given at the investor day presentation it looks like mid feb should be around the time they hit the 230. However on the website it says it will take 52 weeks to fit out Harley street with the LIGHT machine and then treat first patient towards the end of 2020. This could imply the light won’t be ready to instal in Harley street until the end of 2019. Tbh the middle to the end of 2020 was always the aim for regulatory approval and treat first patient so as long as they meet that milestone. Tech updates soon would be good so we know the risk factor has lowered.
Doesn’t really tell us anything. However in 2 months time thE LIGHT Machine would have been tested up to 230mev, Harley street is due to be finished and the LIGHT machine ready to be installed! That will all be a huge piece of news. And the quiet for a year whilst it’s all getting installed and the 2020 first patient treated.
I had read somewhere that the cost would be around £25million per machine. This would tie in with the £24million vendor financing they had secured for The London Proton Therapy Centre (Harley Street). The doomed sale to Sinophi was for $40million. Like you and the company say the construction costs should be lower so a higher price for a superior machine shouldn’t be too bad if the over all project cost is even or less.
These guys are only paying £13m for a Proton Therapy machine. A lot cheaper than the £20-£45 million quoted in the evening standards article for the avo system. https://www.bizjournals.com/stlouis/news/2018/10/23/second-proton-therapy-system-coming-to-barnes.html
https://prod-physicsworld-iop.content.pugpig.com/blog/2018/07/21/proton-therapy-goes-slimline/pugpig_index.html
Farr says testing the machine “is going as expected” but admits that he and his colleagues still face some fairly stiff challenges, particularly when it comes to putting the components together on site – which must be done with millimetre precision over a distance of 24 m. “It is engineering. It is not science,” he says. “We don’t have to discover anything new, we just have to do the work. But we have to do that at a tight level.”
This is just my interpretation of the RNS. I take from it that Thales won�t have as an involved role as previously implied. This is fuelled by the fact the company haven�t answered my emails asking what was happening with the components being moved to Thales from January (as laid out in the timeline issued in March 2017). Rather than this happening alongside Thales� production lines and testing I take from it that it�s instead of but they are still in conversations with Thales about their relationship going forward. Everyone sees things from different angles which is why it�s interesting hearing other people�s views.
This is what the Industrialisation agreement with Thales was meant to do. It was Thales' experience in this area that was going to be used to streamline the production process and drive down cost. Their building in Thonon was meant to be ready to receive the light components in January, this has now been replaced by this agreement. As long as the tech timelines don't slip and come 2020 we can produce enough machines for the expected demand that's fine. This just feels like a dilution of the Thales Thales Industrialisation agreement.